Blog

Patient Support Programmes and Solicited Reports: Capturing Safety Data You Did Not Ask For

Patient support programmes and market research are designed to help patients or gather opinions, not to collect safety data. Yet adverse events surface in both,[…]

DHPCs: Writing and Distributing a Safety Letter That Healthcare Professionals Will Act On

A Direct Healthcare Professional Communication is the most visible safety message a marketing authorisation holder sends. It is also one of the most tightly controlled,[…]

Expedited ICSR Reporting: Day 0, the 15-Day and 90-Day Clocks, and How They Restart

The EU timelines for ICSRs are short and simple to state. The difficulty lies in knowing exactly when the clock started, and in recognising when[…]

Seriousness and Causality in Pharmacovigilance: Two Judgements That Drive Every Report

Seriousness decides how fast a case must be reported. Causality decides whether it is reported at all. Both are judgements, both are often done in[…]

Literature Monitoring for Pharmacovigilance: What the EMA Service Covers and What Remains Yours

Published literature is a source of safety information that companies are expected to screen. The EMA medical literature monitoring service removed a large part of[…]

MedDRA Coding in Pharmacovigilance: Consistency, Versions and the Limits of Automation

MedDRA is the common language of safety data. Every case, every line listing and every signal analysis depends on coding that is consistent from one[…]

ICSR Case Processing and E2B(R3): Where Data Quality Is Won or Lost

An individual case safety report is only as useful as its weakest field. Between the first email from a reporter and the E2B(R3) file that[…]

Warehousing and the Cold Chain: Mapping, Excursions and Inspector Evidence

A temperature-controlled product is only as secure as the least monitored hour of its journey. Most cold chain failures occur in the gaps: a loading[…]

GMP Certificates, MRAs and PIC/S: How Regulators Recognise Inspections

Companies often use “GMP certificate”, “MRA” and “PIC/S” as if they meant the same thing. They do not, and mixing them up leads to wrong[…]

Importing Finished Medicines into the EU: Batch Testing, the QP and MRAs

Every batch of a medicine manufactured outside the EEA must be certified by a Qualified Person in the EEA before it is released, and in[…]

1 … 10 11 12 13 14 … 34